Outrage over executive pay deals
GlaxoSmithKline Plc became the first major British company to have its compensation plan rejected by investors. The proposal was to pay chief executive officer Jean-Pierre Garnier as much as $28 million if he were fired.
Pension & Investments Research Consultants Ltd., whose members oversee more than close to €1 billion of assets, says HSBC director William Aldinger has "one of the most lucrative contracts ever seen in the UK."